Clinical Trial Opportunity for DEE Communities
We’re sharing information about an upcoming opportunity to learn more about a clinical trial for a new treatment under investigation to treat seizures associated with DEE, or Developmental and Epileptic Enchephalopathy.
We’re pleased to invite you to join a 1-hour virtual webinar for families and caregivers navigating severe and rare developmental epilepsies—collectively also known as Developmental and Epileptic Encephalopathy (DEE). This webinar will provide information regarding Lundbeck’s actively enrolling Phase 3 clinical trials, which are studying an investigational compound for the possible treatment of seizures associated with DEE.
Event Details
D.E.E.P. D.I.V.E.: DEE Progress, Data, Insights, Vision, Education Virtual Webinar 1
- Date: Monday, June 1st, 2026
- Time: 8:30 PM ET – 9:30 PM ET
- Location: Zoom (access link and access code provided after registration)
What to Expect
This session will provide information about DEE and Lundbeck’s ongoing clinical research efforts in this space, including:
- An overview of DEE
- An overview of ongoing, actively enrolling Phase 3 clinical studies
- Responses to frequently asked questions
Why Attend?
If you’re seeking a deeper understanding of DEE, this webinar will help clarify important aspects of the condition and share information about Lundbeck’s actively enrolling Phase 3 clinical trials.
When you register, you’ll have the opportunity to submit questions for consideration during the event. You will also be provided with a unique, one-time access code that will allow your entrance to the webinar on the day of the event.
For more information about this event, please reach out to [email protected].
